๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

65-97 - Immunological abnormalities and neuroleptic malignant syndrome (NMS)

โœ Scribed by St. Theodoropoulou; D. Chryssovergl; G. Papageorgiou; C. Leotsakou; A. Tsiroyanni; J. Economidou


Book ID
118512108
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
413 KB
Volume
42
Category
Article
ISSN
0006-3223

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Successful use of risperidone after neur
โœ Ashok N. Singh; David M. Hambidge ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 69 KB

Successful use of risperidone after neuroleptic malignant syndrome (NMS): a 1-year follow-up Neuroleptic malignant syndrome (NMS) is a rare and an acute life-threatening reaction that can occur in patients on neuroleptic medication. Few authors have addressed the issue of re-challenge in previous NM